After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

"FDA lifts hold on Opella’s trial to support switch of Cialis to OTC drug" was originally created and published by Clinical ...

Sanofi is to take on Boehringer Ingelheim's consumer health division in exchange for ... Sanofi will gain access to a number of leading brands across different categories, including digestion ...

Kellanova Australia and New Zealand (ANZ) has announced Michelle Leadbetter as Commercial Director for its Snacks division.

Procter & Gamble and Colgate-Palmolive are among the defendants in six new lawsuits targeting the sale of toothpaste and ...

“Both companies are ‘houses of brands’, in other words a collection of well-diversified luxury businesses serving multiple ...

Fluoride helps prevent cavities when applied topically to the teeth, but when ingested can pose significant risks, even kill ...

Palmolive are among the defendants in six new lawsuits targeting the sale of toothpaste and mouth rinse for young children because the products contain fluoride, which can be harmful if swallowed.

Sanofi’s SNY stock has declined 10.2% in the past three months. However, a lot of this price decline was due to the downtrend of the overall drug and biotech sector, which performed poorly in the past ...

Banks are pitching around €1 billion ($1.05 billion) in debt packages to back a potential buyout of Karo Healthcare, according to people familiar with the matter.

The tie-in with the NFL player marks the continuation of a marketing emphasis on "breaking into culture," says Opella North America CMO.